Sepio Capital LP Cuts Holdings in Teleflex Incorporated (NYSE:TFX)

Sepio Capital LP decreased its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 38.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,653 shares of the medical technology company's stock after selling 2,288 shares during the quarter. Sepio Capital LP's holdings in Teleflex were worth $650,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. HighTower Advisors LLC grew its position in Teleflex by 1.7% during the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company's stock valued at $986,000 after acquiring an additional 66 shares during the last quarter. Hengehold Capital Management LLC raised its position in Teleflex by 7.3% in the 4th quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company's stock worth $229,000 after purchasing an additional 88 shares during the period. Exchange Traded Concepts LLC lifted its stake in Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock worth $61,000 after purchasing an additional 94 shares during the last quarter. Isthmus Partners LLC boosted its position in Teleflex by 7.3% during the fourth quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company's stock valued at $273,000 after buying an additional 105 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd grew its stake in shares of Teleflex by 2.4% during the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,991 shares of the medical technology company's stock valued at $888,000 after buying an additional 118 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company's stock.

Teleflex Stock Up 0.6 %

TFX traded up $0.74 during trading on Friday, reaching $129.81. The stock had a trading volume of 642,249 shares, compared to its average volume of 614,950. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock's 50 day moving average is $148.00 and its two-hundred day moving average is $181.53. The company has a market capitalization of $6.02 billion, a price-to-earnings ratio of 25.81, a P/E/G ratio of 1.73 and a beta of 1.19. Teleflex Incorporated has a one year low of $124.66 and a one year high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating analysts' consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. As a group, analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.05%. The ex-dividend date was Friday, March 7th. Teleflex's dividend payout ratio is presently 95.77%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on TFX shares. Raymond James cut Teleflex from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. StockNews.com cut shares of Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a research note on Wednesday, March 12th. Piper Sandler reissued a "neutral" rating and issued a $140.00 target price (down from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Finally, Truist Financial lowered their price target on Teleflex from $149.00 to $140.00 and set a "hold" rating for the company in a research report on Friday. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, Teleflex currently has a consensus rating of "Hold" and an average price target of $181.50.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.